| Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities Y Liu, W Cao, M Sun, T Li Emerging microbes & infections 9 (1), 194-206, 2020 | 93 | 2020 |
| Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants Y Liu, Z Wang, X Zhuang, S Zhang, Z Chen, Y Zou, J Sheng, T Li, W Tai, ... Nature Communications 14 (1), 2179, 2023 | 20 | 2023 |
| Novel pathways of HIV latency reactivation revealed by integrated analysis of transcriptome and target profile of bryostatin B Li, H Zhang, Y Liu, Y Li, J Zheng, WX Li, K Feng, M Sun, SX Dai Scientific Reports 10 (1), 3511, 2020 | 15 | 2020 |
| A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection W Tai, K Yang, Y Liu, R Li, S Feng, B Chai, X Zhuang, S Qi, H Shi, Z Liu, ... Nature Communications 14 (1), 8042, 2023 | 7 | 2023 |
| High APRIL levels are associated with slow disease progression and low immune activation in chronic HIV-1-infected patients Y Liu, X Li, Y Han, Z Qiu, X Song, B Li, H Zhang, H Wang, K Feng, L Liu, ... Frontiers in medicine 7, 299, 2020 | 6 | 2020 |
| Naïve CD4+ cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by … L Xu, Y Liu, X Song, Y Li, Y Han, T Zhu, W Cao, T Li BMC immunology 22 (1), 36, 2021 | 3 | 2021 |
